Inpharma Weekly

, Volume 1216, Issue 1, pp 14–14 | Cite as

COX-2 inhibitors

benefits over conventional NSAIDs apparent
Newsletter Article


Celecoxib Naproxen American Medical Association Rofecoxib Nabumetone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1999

Personalised recommendations